afamelanotide

FDA Drug Profile — SCENESSE

Drug Details

Generic Name
afamelanotide
Brand Names
SCENESSE
Application Number
NDA210797
Sponsor
Synergy Health AST
NDC Codes
2
Dosage Forms
IMPLANT
Routes
SUBCUTANEOUS
Active Ingredients
AFAMELANOTIDE

Indications and Usage

SCENESSE ® is indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP). SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP)